البروكالسيتونين كعلامة تنبؤية وتشخيصية مبكرة للإنتان عند مرضى السرطان
Abstract
أجريت الدراسة لتقييم كفاءة البروكالسيتونين في تشخيص الإنتان الجرثومي عند مرضى السرطان في مركز المعالجة الكيماوية والشعاعية في مشفى تشرين الجامعي باللاذقية في الفترة الواقعة بين 3\1\2015 إلى 28\3\2016. شملت الدراسة (45) مريضاً كان منهم (25) مريض انتان مثبت و(20) مريض انتان غير مثبت، وجميعهم لديهم حمى وغير متناولين للصادات الحيوية حيث خضع المرضى لتقييم بدئي شامل تضمن فحص سريري دقيق وفحوص مخبرية عديدة وصور شعاعية كما تم قياس البروكالسيتونين أثناء الترفع الحروري ومقارنته مع البروتين المتفاعل C، وأشارت النتائج الى وجود ارتباط هام بين البروكالسيتونين والانتان حيث كانت القيم الوسطية للبروكالسيتونين عند مرضى الانتان المثبت 16.9 نغ/مل مقابل 0.7 نغ/مل عند مرضى الانتان غير المثبت، كما ترافق ازدياد تركيز البروكالسيتونين مع زيادة شدة الانتان، واظهرت الدراسة أن البروكالسيتونين أكثر حساسية ونوعية من ال CRP في تشخيص وجود انتان عند مرضى السرطان. The study is carried out to estimate the efficiency of Procalcitonin in the diagnosis of bacterial infection in cancer patients at Chemical and Radiation Therapy Center in Tishreen University Hospital in Lattakia between 3/1/2015-28\3\2016. This study has included 45 patients, 25 with infection and 20 without infection, all of them have a fever and don't take antibiotics. The all of patients has undergone a comprehensive initial assessment included history, physical examination, biochemical parameters and X-ray images. Procalcitonin was also measured during fever and compared with C-reactive protein CRP, the results indicated that there is a significant correlation between Procalcitonin and infection, where the median values Procalcitonin in patients with infection 16.9 ng/ml compared to 0.7 ng/ml in patients without infection, Procalcitonin concentration was also associated with the severity of the infection, the study showed that the Procalcitonin is more sensitive and specific of the CRP in diagnosing of sepsis in cancer patients.Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.